This inventor holds 1 USPTO granted patent. Top assignee: Creighton University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations in Cancer Treatment by Harrison Kramer
Introduction
Harrison Kramer is an innovative inventor based in Phoenix, AZ, who has made significant contributions to the field of cancer treatment. His work focuses on enhancing radiation therapy through the use of biocompatible quantum dots. With a single patent to his name, Kramer is dedicated to improving the efficacy of cancer treatments.
Latest Patents
Kramer's notable patent is titled "Cancer radiation therapy with biocompatible quantum dots for simultaneous dose enhancement and counter-metastasis." This patent describes systems and methods for radiation therapy aimed at cancerous tumors. The invention utilizes biocompatible quantum dots to provide radiation dose enhancement and resistance to metastasis. The method involves preparing a radiosensitizer fluid containing a plurality of biocompatible quantum dots, introducing this fluid to cancer cells, and subsequently irradiating the cells. This process promotes the generation of reactive oxygen species while inhibiting radiation-induced enhancement of cell migration.
Career Highlights
Harrison Kramer is affiliated with Creighton University, where he continues to advance his research in cancer therapy. His innovative approach to utilizing quantum dots in radiation therapy showcases his commitment to finding effective solutions for cancer treatment.
Collaborations
Kramer collaborates with talented individuals such as Andrew Edet Ekpenyong and Caleb Thiegs, who contribute to his research efforts and help drive innovation in the field.
Conclusion
Harrison Kramer is a pioneering inventor whose work in cancer radiation therapy represents a significant advancement in medical technology. His dedication to improving treatment methods through innovative approaches is commendable and holds promise for future breakthroughs in cancer care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
